Document Detail

Intracranial multifocal dural involvement in multiple myeloma: case report and review of the literature.
MedLine Citation:
PMID:  20511169     Owner:  NLM     Status:  MEDLINE    
Multiple myeloma is an incurable clonal B-cell malignancy with terminally differentiated plasma cells that accounts for 1% of all malignancies in the United States. It may present with tumors consisting of discrete masses of neoplastic monoclonal plasma cells in either bone or soft tissues. Central nervous system (CNS) involvement of myeloma is uncommon and is observed in approximately 1% of cases. It may manifest as dural myeloma or intraparenchymal infiltration, or with diffuse leptomeningeal involvement. Dural involvement of myeloma without parenchymal or leptomeningeal disease is an even rarer occurrence, with only 5 cases reported in the medical literature. There are no established treatment guidelines for CNS myelomatosis; prognosis and literature on the use of treatment modalities for this complication is reviewed herein.
Carlos E Méndez; Becky J Hwang; Sylvie Destian; Amitabha Mazumder; Sundar Jagannath; David H Vesole
Related Documents :
1290479 - Granuloma annulare of the penis.
637639 - Myelofibrosis associated with multiple myeloma.
15727239 - Devic's neuromyelitis optica and mitochondrial dna mutation: a case report.
9719009 - Jejunal lipomatosis with diverticulosis: report of a case.
10210909 - Frontal type dementia preceding amyotrophic lateral sclerosis: a neuropsychological and...
22280859 - From identification and review to action-maternal mortality review in the united states.
20630599 - Interferon alfa-associated anterior ischemic optic neuropathy.
12622509 - Fractionated stereotactic radiotherapy: a short review.
21826149 - Fetal cervical neuroblastoma: prenatal diagnosis.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Clinical lymphoma, myeloma & leukemia     Volume:  10     ISSN:  2152-2669     ISO Abbreviation:  Clin Lymphoma Myeloma Leuk     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-31     Completed Date:  2010-08-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101525386     Medline TA:  Clin Lymphoma Myeloma Leuk     Country:  United States    
Other Details:
Languages:  eng     Pagination:  220-3     Citation Subset:  IM    
Division of Hematology and Oncology, Department of Medicine, St. Vincent's Comprehensive Cancer Center, New York, NY 10011, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Boronic Acids / administration & dosage
Cisplatin / administration & dosage
Cyclophosphamide / administration & dosage
Dexamethasone / administration & dosage
Doxorubicin / administration & dosage
Dura Mater / pathology*
Fatal Outcome
Meningeal Neoplasms / drug therapy,  pathology*
Middle Aged
Multiple Myeloma / drug therapy,  pathology*,  physiopathology
Pyrazines / administration & dosage
Thalidomide / administration & dosage,  analogs & derivatives
Reg. No./Substance:
0/Boronic Acids; 0/Pyrazines; 0/bortezomib; 15663-27-1/Cisplatin; 191732-72-6/lenalidomide; 23214-92-8/Doxorubicin; 50-02-2/Dexamethasone; 50-18-0/Cyclophosphamide; 50-35-1/Thalidomide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment With Bortezomib of a Patient Having Hyper IgG4 Disease.
Next Document:  A time for growth.